| Bioactivity | ARF1 (2-17) inhibits both ARF-independent (PLC-β) and ARF-dependent (PLD) pathways. ARF1 (2-17) inhibits GTP-γ-S-stimulated PLD activity, phospholipase C-β (PLC-β), and exocytosis[1]. |
| CAS | 143228-35-7 |
| Sequence | Gly-Asn-Ile-Phe-Ala-Asn-Leu-Phe-Lys-Gly-Leu-Phe-Gly-Lys-Lys-Glu |
| Shortening | GNIFANLFKGLFGKKE |
| Formula | C85H131N21O21 |
| Molar Mass | 1783.08 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Fensome A, et al. ARF1(2-17) does not specifically interact with ARF1-dependent pathways. Inhibition by peptide of phospholipases C beta, D and exocytosis in HL60 cells. FEBS Lett. 1994 Jul 25;349(1):34-8. |
ARF1 (2-17)
CAS: 143228-35-7 F: C85H131N21O21 W: 1783.08
ARF1 (2-17) inhibits both ARF-independent (PLC-β) and ARF-dependent (PLD) pathways. ARF1 (2-17) inhibits GTP-γ-S-stimu
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.